EMcd-Emergency Medicine - Cardiology: Atrial Fibrillation; Congestive Heart Failure; Carditis is organized by American Medical Seminars (AMS), Inc. This course has been approved for a maximum of 5 AMA PRA Category 1 Credits™.
Original Release Date: July 1, 2020
Expiration Date: July 1, 2023
Topic 1: Atrial Fibrillation
Upon completion of this session, the participant should be able to: EBM, GL, COMP
• Relate the importance of anticoagulation, based upon CHADS2VASC Risk Scores and the ACC/AHA Guidelines in the management of atrial fibrillation.
• List various pharmaceutical and non-pharmaceutical methods of normalizing ventricular rate.
• Compare two possible strategies for cardioversion in atrial fibrillation.
• Assess the potential benefit and harm of antiarrhythmic therapies.
Topic 2: Congestive Heart Failure.
Upon completion of this session, the participant should be able to: GL, COMP
• Recognize the symptoms of congestive heart failure and appropriately Stage as per the ACC/AHA Guidelines.
• Identify common causes of systolic heart failure.
• Employ current ACCF/AHA Guidelines and standard-of-care therapies, differentiating between those treatments which reduce mortality and those that improve symptoms.
Topic 3: Distinguishing, Diagnosing, and Treating Carditis: Pericarditis, Myocarditis, and Endocarditis.
Upon completion of this session, the participant should be able to: EBM, GL, COMP
• Determine the indication and timing of cardiac MRI and/or endomyocardial biopsy to delineate the etiology, prognosis, and treatment course in acute myocarditis using evidence-based medicine.
• Recognize acute myocarditis when treating a new acute heart failure patient.
• Apply evidence-based medicine treatment strategies in acute pericarditis.
• Identify and apply ACC/AHA/ASE guideline-directed patient selection for transesophageal echocardiogram in suspected or confirmed acute endocarditis
• Apply ACC/AHA guidelines in the management and timing of operative referral for acute endocarditis
Copyrights © 2023 eMedEvents Corporation, All Rights Reserved.